Cardlytics Inc (CDLX) — Capital Reinvestment Ratio
Latest as of December 2025:
0.00x
Cardlytics Inc (CDLX) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($13.01 Million) in capital expenditures ($25.00K). See Cardlytics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$13.01 Million
USD
Capital Expenditures
$25.00K
USD
Data as of
Dec 2025
Most recent filing
Cardlytics Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Cardlytics Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Cardlytics Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Cardlytics Inc from 2019 to 2025. For live market cap and broader valuation context, see CDLX company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | $9.29 Million | $480.00K | ▼ -94.6% |
| 2019 | 0.96x | $11.46 Million | $11.02 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow